University Hospital, Strasbourg, France: Multiple Sclerosis trials

The registry lists 10 Multiple Sclerosis studies with University Hospital, Strasbourg, France as lead sponsor. 6 are open to participants now and 0 have results posted.

Phase 3 1Phase 4 2No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Assessment of the Frequency of Functional Neurological Disorders in Multiple Sclerosis and Analysis of Clinical and Psychological DeterminantsNot yet recruitingNCT07849816
• Internuclear Ophthalmoplegia and Multiple Sclerosis: a Multicenter Retrospective StudyNot yet recruitingNCT07560995
• Multicenter Prospective Study Analyzing the Occurrence of Multiple Sclerosis Relapses Without Radiological Evidence: Myth or Reality?Not yet recruitingNCT07545889Not applicable
• Escalation vs. Induction Therapy Strategy in Patients With Early-Onset MS After Age 50RecruitingNCT07313462
• Disease Modifying Therapies Withdrawal in Inactive Relapsing-remitting Multiple Sclerosis Patients Aged 55 and Over (TWINS : Therapies Withdrawal IN Relapsing Multiple Sclerosis)Not yet recruitingNCT06663189Phase 3
• Comparison of Diagnostic Performances of 3D FLAIR, DIR and PSIR Sequences in Optic NeuritisRecruitingNCT06494228
• Cladribine Tablets as an Exit Therapy StrategyCompletedNCT06887426
• Retrospective Study on Registry Data to Evaluate the Impact of Ocrelizumab Used in Routine Care in Patients With RRMSStatus unknownNCT04838015
• Evaluation of Early Changes Visible to the Diffusion MRI in Response to Two Years of Treatment With Tysabri in Patients With Multiple SclerosisTerminatedNCT02904876Phase 4
• Magnetic Resonance Imaging (MRI) Follow-up of Macrophagic Infiltration in MS Patients Treated With TysabriTerminatedNCT00752778Phase 4